scispace - formally typeset
L

Lucinda L. Miner

Researcher at University of Colorado Boulder

Publications -  19
Citations -  2973

Lucinda L. Miner is an academic researcher from University of Colorado Boulder. The author has contributed to research in topics: Nicotine & Convulsion. The author has an hindex of 15, co-authored 19 publications receiving 2913 citations. Previous affiliations of Lucinda L. Miner include National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia

TL;DR: The results implicate endogenous opioid-peptide actions at mu opiate receptors in several tests of nociceptive responsiveness and support mu receptor mediation of morphine-induced analgesia in tests of spinal and supraspinal analgesia.
Journal ArticleDOI

VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity

TL;DR: Transgenic VMAT2 knockout mice are constructed and novel information about the contributions of synaptic vesicular actions of monoaminergic drugs and neurotoxins are provided and it is suggested that intactaptic vesicle function may contribute more to amphetamine-conditioned reward than to amphetamines-induced locomotion.
Journal ArticleDOI

Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors

TL;DR: A significant relationship was observed between BTX binding in the three brain regions and sensitivity to IV nicotine-induced seizures such that strains with greater concentrations of BTXbinding sites were more sensitive to nicotine- induced seizures than were strains with lower concentrations ofBTX binding sites.
Journal Article

Classical genetic analysis of nicotine-induced seizures and nicotinic receptors.

TL;DR: Strain differences for both seizure sensitivity and receptor concentration in the hippocampus may be due to allelic differences at a single autosomal locus, with dominance for low seizure susceptibility and fewer alpha-BTX receptors.